- Home
- MCRB vs AVD Comparison
MCRB vs AVD Comparison
Compare MCRB & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- AVD
- Stock Information
- Founded
- MCRB 2010
- AVD 1969
- Country
- MCRB United States
- AVD United States
- Employees
- MCRB N/A
- AVD N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- AVD Agricultural Chemicals
- Sector
- MCRB Health Care
- AVD Industrials
- Exchange
- MCRB Nasdaq
- AVD Nasdaq
- Market Cap
- MCRB 165.3M
- AVD 158.9M
- IPO Year
- MCRB 2015
- AVD N/A
- Fundamental
- Price
- MCRB $15.91
- AVD $5.61
- Analyst Decision
- MCRB Hold
- AVD Strong Buy
- Analyst Count
- MCRB 4
- AVD 1
- Target Price
- MCRB $73.67
- AVD $12.00
- AVG Volume (30 Days)
- MCRB 245.4K
- AVD 165.0K
- Earning Date
- MCRB 11-12-2025
- AVD 11-10-2025
- Dividend Yield
- MCRB N/A
- AVD N/A
- EPS Growth
- MCRB N/A
- AVD N/A
- EPS
- MCRB 10.22
- AVD N/A
- Revenue
- MCRB N/A
- AVD $529,067,000.00
- Revenue This Year
- MCRB N/A
- AVD N/A
- Revenue Next Year
- MCRB N/A
- AVD $3.54
- P/E Ratio
- MCRB $1.62
- AVD N/A
- Revenue Growth
- MCRB N/A
- AVD N/A
- 52 Week Low
- MCRB $6.53
- AVD $3.28
- 52 Week High
- MCRB $24.67
- AVD $6.68
- Technical
- Relative Strength Index (RSI)
- MCRB 44.26
- AVD 62.42
- Support Level
- MCRB $17.00
- AVD $5.24
- Resistance Level
- MCRB $24.67
- AVD $5.84
- Average True Range (ATR)
- MCRB 2.01
- AVD 0.25
- MACD
- MCRB -0.50
- AVD -0.03
- Stochastic Oscillator
- MCRB 15.94
- AVD 70.13
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.